Introduction
Ring-closing metathesis (RCM) is now a commonly employed technique for the construction of cyclic peptidomimetics. [1] The installation of a carbon-based bridge can be used to stabilize bioactive turns, [2] replace metabolically unstable cystine bridges, [3] and stabilize peptide backbones to peptidase activity. [4] Reasons for its increasing popularity include the commercial availability of ruthenium alkylidene catalysts, the tolerance of these catalysts to a wide range of functionality, and the use of solid-phase peptide synthesis (SPPS) to incorporate metathesisactive residues. Since RCM reactions are rarely stereoselective, although new catalysts are showing promise in this area, [5] mixtures of E-and Z-alkenes usually result after ring closure. These unsaturated dicarba isomers are often easily separated, or alternatively reduced as a mixture to generate the saturated dicarba peptide (Scheme 1). [3a,b] Hence, a small library of peptide analogues can be quickly assembled from a common linear precursor to probe structure-activity relationships.
Not all linear peptides undergo facile RCM, and the yield of these reactions is often highly dependent on the peptide primary sequence. [6] Microwave irradiation, [3a,b,7] chaotropic salts, [8] and turn-inducing pseudoproline residues [9] can all be used to overcome competing aggregation phenomena to promote ring closure. However, even after employing such strategies, in a small but growing number of cases, RCM still fails to provide viable yields of cyclic peptide. We have found that this situation arises quite often in sequences possessing a large number, or sequential string, of hydrophobic residues. A second challenge arises in the installation of multiple dicarba bridges within a peptide sequence. For instance, the construction of three rings, via metathesis of six sequence-installed allylglycine (Agl) residues, can theoretically give rise to 15 topoisomers. Subsequent isolation of the target isomer from the resultant mixture would be non-viable. Clearly, methods which facilitate regioselective construction are highly desirable. This paper describes the development of an interrupted SPPS-catalysis method to overcome the aforementioned challenges. The process is generic and sequentially installs carbocyclic rings via an alternating combination of alkene metathesis, hydrogenation, and SPPS. This approach completely eliminates topoisomer formation and also facilitates quantitative RCM in highly problematic aggregation-prone peptide sequences.
Results and Discussion
The interrupted SPPS-catalysis approach is exemplified with peptide 1, a 19-amino acid sequence composed of mainly hydrophobic residues and three 17-membered rings. High yielding construction of this peptide from a full linear sequence (Agl-API-Agl-SL-Agl-API-Agl-SL-Agl-API-Agl-SLG) would not be successful. Furthermore, even RCM on a resin-supported, truncated 11-mer (ASL-Agl-API-Agl-SLG), where the N-terminal allylglycine residue is flanked by three adjacent N-terminal residues, is problematic. Only poor conversion (28%) was observed under optimum metathesis conditions, and reduction of the newly installed C¼C linkage was also incomplete.
Such behaviour has also been reported by Vederas [10] and Ginanneschi [11] and is a significant problem for several reasons. In a single ring forming event, a retarded metathesis reaction complicates product purification (i.e. each metathesis cycle generates a mixture of two isomeric C¼C peptides (E-and Z-) and the starting linear material); this problem then compounds with each additional cyclization. The inability to hydrogenate the product also complicates purification (i.e. eight isomers would comprise a 'pure' tricyclic peptide mixture) and reduces yield because both isomers cannot be reduced to the same saturated carbocycle. Furthermore, the inability to reduce the newly installed C¼C can also complicate subsequent RCM reactions and result in ring-opening metathesis leading to loss of topoisomer selectivity. Significantly, we have found that temporary exclusion of the N-terminal residues not involved in ring formation, i.e. terminating the sequence at the second allylglycine residue, can greatly assist both Ru-alkylidene-catalyzed RCM and hydrogenation. Without the 'tail' residues, the peptide is able to adopt a favourable conformation for RCM and hydrogenation catalyst penetration. The newly formed C¼C bridge is also readily reduced under homogeneous Rh(I)-catalyzed hydrogenation conditions when the N-terminal residues are absent. Since both these steps are conducted on the solid-phase, the peptide can be readily subjected to further SPPS after catalysis to incorporate residues for a second carbocycle. The above described catalysis steps are then repeated.
Automated, microwave-accelerated SPPS using HBTUHOBt-DIPEA activation and Fmoc-protected amino acids was used to construct the linear sequence 2 on Fmoc-Gly-Wang resin (Scheme 2). During the synthesis of the linear sequence, intermediate peptides were carried through without purification or characterization up to the octapeptide 2. A resin aliquot of the peptide was removed and subjected to acid-mediated cleavage. Mass spectral analysis gave a molecular ion peak at m/z 751.3 [MþH] þ which was consistent with the structure of the sidechain-deprotected linear peptide 2. An additional peak at m/z 664.1 [MþH] þ , corresponding to a serine deletion product, was also apparent in the spectrum of peptide 2 (Fig. 1a) . Gratifyingly, exposure of resin-bound 2 to second generation Grubbs' catalyst 3 (20 mol-%) in dichloromethane and 5% 0.4 M LiCl, under microwave irradiation (100 W) resulted in complete ring closure. Mass spectral analysis of a cleaved aliquot of the product mixture showed a molecular ion peak at m/z 723.2 [MþH] þ for the unsaturated dicarba peptide 4 and no ions indicating C¼C isomerization (i.e. m/z AE 14 amu) were observed. Curiously, reverse phase (RP)-HPLC analysis of the crude peptide gave an uncharacteristically broad peak (Fig. 1b) . The RCM process would be expected to generate both E-and Z-isomers, but the exaggerated peak broadening could be the result of conformation restriction imposed by the C¼C linkage. Significantly, in the absence of the peptide 'tail', hydrogenation was straightforward. Reduction of the resin-bound carbocycle 4 was performed under 80 psi of hydrogen with Wilkinson's catalyst, Rh(I)(PPh 3 ) 3 Cl, in a mixture of CH 2 Cl 2 -MeOH (9:1). The mass spectrum of a cleaved peptide aliquot displayed a molecular ion peak consistent with the formation of the saturated dicarba peptide 5 and the RP-HPLC trace now showed a sharp peak with a longer retention time (Fig. 1c) . Importantly, the peptide remained attached to the resin throughout these two catalytic cycles and was immediately available for a second round of SPPS.
The linear sequence 5 was extended by seven residues, which included the requisite pair of allylglycine residues. The resultant 14-mer 6 was then subjected to RCM (to give 7) and hydrogenation (to give 8) to install a second saturated carbocycle. Both catalysis steps proceeded with excellent conversion, and in each case no starting peptide could be detected in the RP-HPLC chromatograms ( Fig. 1e and 1f) or crude mass spectra. The final ring was installed into the sequence via the same protocol described above (i.e. 8 -9 -10 -1, Scheme 2 and Fig. 1f-1i ). Final cleavage from the resin and preparative RP-HPLC purification of the crude peptide yielded the tricyclic peptide 1 in 3% yield and .99% purity (Fig. 1j) .
Conclusion
We have now applied the above described interrupted SPPScatalysis approach to several peptide sequences and believe that it provides a generic and high yielding method for dicarba bridge installation and reduction in peptides. Our methodology has also been shown to be invaluable for achieving RCM in hydrophobic peptides, and for the regioselective installation of multiple rings. [12] The method is highly flexible, and product design is completely controlled by the primary sequence: the size of the rings can be varied by altering the number of residues between the metathesis-active groups and the rings themselves can be the same (as described in this paper) or different. The spacer residues, the amino acids between the carbocycles, can be varied in number, and residues both in this region and the rings can be used to promote higher order structure such as helices and stacked rings.
Experimental

General Instrumentation
Low resolution electrospray ionization (ESI) mass spectra were recorded on a micromass platform electrospray mass spectrometer (QMS-quadrupole mass electroscopy) as solutions in specified solvents. Spectra were recorded in the positive mode (ESI þ ). The mass spectrometer was calibrated with an internal standard solution of sodium iodide in MeOH. Analytical RP-HPLC was performed on an Agilent 1200 series instrument equipped with photodiode array (PDA) detection (controlled by ChemStation software) and an automated injector (100 mL loop volume). Analytical separations were performed on a Vydac C18 (4.6 Â 250 mm, 5 mm) analytical column at flow rates of 1.5 mL min
À1
. Preparative RP-HPLC was performed on an Agilent 1200 series instrument equipped with multivariable wavelength detection (controlled by ChemStation software) and an Agilent unit injector (2 mL loop volume). Preparative separations were performed on a Vydac C18 (22 Â 250 mm, 10 mm) preparative column at flow rates of 10 mL min À1 . The solvent system used throughout this study was buffer A: 0.1% aqueous TFA and buffer B: 0.1% TFA in MeCN. Linear gradients of 0.1% TFA in MeCN (buffer B) were employed as specified.
Peptide Materials and Procedures
Manual solid phase peptide synthesis (SPPS) was performed in polypropylene Terumo syringes (5 mL) fitted with a porous (20 mm) polyethylene filter. Resin wash and filtering steps were aided by the use of a Visprep TM SPE DL 24-port model vacuum manifold as supplied by Supelco. Capping reactions and cleavage mixtures were shaken on a KS125 basic KA elliptical shaker supplied by Labortechnik at 400 motions per minute. Cleaved peptides were collected by centrifugation at a speed of 6000 rpm in a TMC-1 mini centrifuge supplied by Thermoline. Commercially available L-amino acids, including allylglycine, were used in this study.
Microwave-accelerated SPPS Procedure
Automated microwave-accelerated SPPS was carried out using a CEM Liberty-Discover TM synthesizer, involving the flow of dissolved reagents from external nitrogen-pressurized bottles to a resin-containing microwave reactor vessel fitted with a porous filter. Coupling and deprotection reactions were carried out within this vessel and were aided by microwave energy. Each reagent delivery, wash, and evacuation step was carried out according to the automated protocols of the instrument (controlled by PepDriver software). In a 50 mL centrifuge tube, Fmoc-Gly-Wang resin/Fmoc-peptide-resin (0.53 mmol g À1 ) was swollen with DMF:CH 2 Cl 2 (1:1; 10 mL, 1 Â 60 min) and connected to the Liberty TM resin manifold. The Fmoc-amino acids (0.2 M in DMF), activators (0.5 M HBTU:HOBt in DMF), activator base (2 M DIPEA in NMP) and deprotection agent (20% v/v piperidine in DMF) were measured out and solubilized in an appropriate volume of specified solvent as calculated by the PepDriver software program. The default microwave conditions used in the synthesis of each linear peptide included: initial deprotection (36 W, 378C, 2 min), deprotection (45 W, 758C, 10 min), pre-activation (0 W, 258C, 2 min), and coupling (25 W, 758C, 10 min). After synthesis completion, the resinbound peptides were automatically returned to the Liberty TM resin manifold as a suspension in DMF:CH 2 Cl 2 (1:1) and filtered through fritted plastic syringes (5 mL) for acid-mediated cleavage. Prior to catalysis, the peptidyl-resins were treated with an acetic anhydride capping solution (4 mL; 94:5:1; DMF:acetic anhydride:NMM) for 2 h, filtered, washed with DMF (3 Â 1 min), CH 2 Cl 2 (3 Â 1 min) then MeOH (3 Â 1 min), and dried under vacuum for 30 min.
TFA Cleavage Procedure
A small aliquot of resin-bound peptide (approximately 3 mg) was suspended in cleavage solution (1 mL; 95:2.5:2.5; TFA: TIPS:water) and shaken gently for 2 h. The mixture was filtered through a fritted syringe and the beads rinsed with TFA (1 Â 0.2 mL). The filtrate was concentrated under a constant stream of air and the resultant oil was induced to precipitate in ice-cold Et 2 O (1 mL). Cleaved peptides were collected by centrifugation (3 Â 5 min) and dried for analysis by analytical RP-HPLC and mass spectrometry.
Catalytic Materials and Procedures
Tricyclohexylphosphine[1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene] (benzylidene)ruthenium(II) dichloride (2nd generation Grubbs' catalyst, 3) and tris(triphenylphosphine)rhodium(I) chloride (Wilkinson's catalyst, Rh(PPh 3 ) 3 Cl) were used as supplied by Aldrich and stored in a nitrogen-filled dry box. High purity (,10 ppm oxygen) argon and hydrogen were supplied by BOC gases and additional purification was achieved by passage of the gases through water, oxygen, and hydrocarbon traps. The CH 2 Cl 2 , MeOH, and chaotropic salt solution (0.4 M LiCl in DMF) used in all metal-catalyzed metathesis and hydrogenation reactions were degassed with high purity argon before use. Microwave ring-closing metathesis (RCM) and hydrogenation reactions were carried out on a CEM Discover TM system fitted with the Benchmate TM or Gas Addition TM option. The instrument produces a continuous focussed beam of microwave radiation delivered at a maximum power as selected by the user, which reaches and maintains a programmed temperature. Reactions were performed in 10 mL high pressure glass microwave vessels fitted with self-sealing Teflon septa as a pressure relief device. The vessels employ magnetic stirrer beads, and the temperature of each reaction was monitored continuously with a non-contact infrared sensor located below the microwave cavity floor or with a glass enclosed fibre optic temperature probe. Reaction times were measured from the time the microwave reached its maximum temperature until the programmed reaction period had lapsed (cooling periods not inclusive).
Microwave-accelerated RCM Procedure
A microwave reactor vessel was loaded with substrate, deoxygenated solvent, deoxygenated chaotropic salt solution, and catalyst in an inert (nitrogen) environment. The system was sealed and the reaction mixture irradiated with microwave energy whilst being stirred at a specified temperature, for the specified period of time. After cooling to room temperature, the resin-bound peptide was filtered through a fritted syringe and washed with CH 2 Cl 2 (4 mL, 3 Â 1 min), DMF (4 mL, 3 Â 1 min) then MeOH (4 mL, 3 Â 1 min), and dried under vacuum for 30 min. A small aliquot of resin was then subjected to acid-mediated cleavage and the isolated solid was analyzed by RP-HPLC and mass spectrometry. Metathesis experiments are described using the following format: substrate (mmol), solvent (mL), additive (mL), catalyst (mol-%), microwave power (W), reaction temperature (8C), reaction time (h), and % conversion.
Microwave-accelerated Hydrogenation Procedure
Microwave hydrogenation reactions were carried out on a CEM Discover TM system fitted with the Gas Addition TM option. A microwave reactor vessel was loaded with substrate, deoxygenated solvent, and catalyst in an inert (argon or nitrogen) environment. The system was sealed and the pressure vessel was then connected to a vacuum manifold and purged three times using vacuum and argon flushing cycles. After charging the vessel with hydrogen gas to the stated pressure, the reaction mixture was irradiated with microwave energy whilst being stirred at the specified temperature for a specified period of time. Once cooled to room temperature, the hydrogen gas was vented from the system, and catalyst deactivation was achieved by exposure to oxygen. The resin-bound peptide was then filtered through a fritted syringe and washed with CH 2 Cl 2 (4 mL, 3 Â 1 min), DMF (4 mL, 3 Â 1 min) then MeOH (4 mL, 3 Â 1 min), and dried under vacuum for 30 min before resin cleavage. Hydrogenation experiments are described by the following format: substrate (mmol), solvent (mL), additive (mL), catalyst (,3 mg), hydrogen pressure (psi), microwave power (W), reaction temperature (8C), and reaction time (h).
Synthetic Procedures
Agl-API-Agl-SLG (2) Synthesis of the linear sequence 2 was performed according to the microwave-accelerated SPPS procedure described previously using Fmoc-Gly-Wang resin (377 mg, 200 mmol Agl-API-Agl-SL-c[Das-API]-SLG (6) Synthesis of the extended sequence 6 was performed according to the microwave-accelerated SPPS procedure described previously on Fmoc-cyclic peptide-Wang resin 5 (490 mg, 200 mmol). RP-HPLC and mass spectral analysis of an aliquot of Fmoc-and resin-cleaved peptide supported the formation of the required sidechain-deprotected peptide 6 in 89% purity. The serine deletion product (11%) detected in 2 was also still apparent in the spectral data. Mass spectrum (ESI 
Das-API]-c[Das-API]-SLG (7)
Resin-bound peptide 6 was subjected to the microwaveaccelerated RCM procedure described previously under the following conditions: 6 (579 mg, 200 mmol), CH 2 Cl 2 (4.75 mL), 0.4 M LiCl in DMF (0.25 mL), 2nd generation Grubbs' catalyst 3 (34 mg, 40 mmol), 100 W, 808C, 4 h, 100% conversion into 7. RP-HPLC and mass spectral analysis of an aliquot of Fmoc-and resin-cleaved peptide supported formation of the required unsaturated bicyclic peptide 7. 
